Reg Jones to Hand Over Stratagene CFO Post to Steven Martin; Cristopher McReynolds Goes to Galapagos from Cepheid; Ferdinand Verdonck and Harrold van Barlingen Join Galapagos Board; Russell Bradly New VP Business Development at Luminex; and Others | GenomeWeb

Reg Jones will retire as chief financial officer of Stratagene, effective June 30, the company said last week. Jones, who will remain a company consultant, will be replaced by Steve Martin, the company's director of finance. Prior to joining Stratagene a year ago, he was the controller of GenProbe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.